{"id":23625,"date":"2026-01-14T20:33:07","date_gmt":"2026-01-14T20:33:07","guid":{"rendered":"https:\/\/www.europesays.com\/africa\/23625\/"},"modified":"2026-01-14T20:33:07","modified_gmt":"2026-01-14T20:33:07","slug":"fmd-disease-outbreak-in-south-africa","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/africa\/23625\/","title":{"rendered":"FMD disease outbreak in South Africa"},"content":{"rendered":"<p><a href=\"https:\/\/farmersreviewafrica.com\/wp-content\/uploads\/2026\/01\/Banco-de-antigenos-Antigen-Bank-e1768419664662.png\" data-caption=\"\" rel=\"nofollow noopener\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" data-lazyloaded=\"1\" width=\"696\" height=\"392\" class=\"entry-thumb td-modal-image\" src=\"https:\/\/www.europesays.com\/africa\/wp-content\/uploads\/2026\/01\/Banco-de-antigenos-Antigen-Bank-696x392.png\"  data- alt=\"\" title=\"Banco de ant\u00edgenos - Antigen Bank\"\/><\/a><\/p>\n<p>The Argentine company joins the national strategy to fight foot-and-mouth disease, providing high-potency vaccines against the SAT 1, SAT 2 and SAT 3 strains, with the aim of drastically reducing outbreaks and contributing to the recovery of the country\u2019s health status. <\/p>\n<p>Biog\u00e9nesis Bag\u00f3 announced the shipping of foot-and-mouth disease vaccines to South Africa, which will be part of the national vaccination plan designed to contain and eradicate the disease within ten years. The agreement includes an initial shipment of 1 million doses of high-potency vaccines, ready to be dispatched as soon as the corresponding regulatory authorizations are issued, and an additional supply of 5 million doses before March 2026 against the SAT 1, SAT 2 and SAT 3 serotypes that generated outbreaks in the country with significant consequences for meat and milk production.<\/p>\n<p>The doses provided by Biog\u00e9nesis Bag\u00f3 will be integrated into massive vaccination campaigns in phases, focused on outbreaks identified through risk maps (heatmaps), with coverage goals of more than 80% in communal herds and up to 100% in feedlots and dairy farms. This contribution will complement local production and the agreements that South Africa has with other institutions in the region, strengthening the availability of trivalent vaccines adapted to the SAT (South African Territories) strains currently circulating in the country.<\/p>\n<p>The South African program combines the use of high-potency vaccines with a reinforcement of epidemiological surveillance, traceability and movement control, with the aim of significantly reducing the incidence of outbreaks in the most affected provinces over the next 12 months. In the medium term, the strategy plans to move towards the consolidation of disease control and, finally, the progressive withdrawal of vaccination once the health objectives established by international organizations have been achieved<\/p>\n<p>Desde Biog\u00e9nesis Bag\u00f3 destacaron que este acuerdo se apoya en la amplia experiencia de la compa\u00f1\u00eda en la lucha contra la fiebre aftosa y en su capacidad industrial para responder a emergencias sanitarias de gran escala. \u201cNuestra misi\u00f3n es acompa\u00f1ar a los pa\u00edses en el dise\u00f1o e implementaci\u00f3n de estrategias sostenibles de control y erradicaci\u00f3n de la aftosa, combinando tecnolog\u00eda de punta, capacidad de producci\u00f3n y conocimiento epidemiol\u00f3gico\u201d, se\u00f1al\u00f3 Rodolfo Bellinzoni, Director de Operaciones e Innovaci\u00f3n de Biog\u00e9nesis Bag\u00f3.<\/p>\n<p>Biog\u00e9nesis Bag\u00f3 emphasized that this agreement is based on the company\u2019s extensive experience in the fight against foot-and-mouth disease and its industrial capacity to respond to large-scale health emergencies. \u201cOur mission is to help countries in the design and implementation of sustainable strategies for the control and eradication of foot-and-mouth disease, combining state-of-the-art technology, production capacity and epidemiological knowledge,\u201d said Rodolfo Bellinzoni, Chief of Industrial Operations and Innovation at Biog\u00e9nesis Bag\u00f3.<\/p>\n<p>\u201cThe commitment to South Africa adds to our track record of successful disease control programs in Latin America and Asia, where the systematic use of our vaccines contributed to recovering and sustaining FMD-free status with and without vaccination,\u201d he added.<\/p>\n<p>Biog\u00e9nesis Bag\u00f3 also acts as a supplier of antigens and vaccines for antigen banks against foot-and-mouth disease, facilitating a rapid and flexible response to the emergence of new outbreaks and viral variants. \u201cBeing an antigen bank supplier to the world\u2019s leading meat exporters such as Brazil and the United States has given us a unique platform to quickly adapt our solutions to the relevant field strains in each region. That same experience will now be at the service of South Africa, as a strategic partner in its roadmap towards a country free of foot-and-mouth disease and with greater health resilience,\u201d Bellinzoni concluded.<\/p>\n","protected":false},"excerpt":{"rendered":"The Argentine company joins the national strategy to fight foot-and-mouth disease, providing high-potency vaccines against the SAT 1,&hellip;\n","protected":false},"author":2,"featured_media":23626,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52],"tags":[14511,14512,14513,14514,14515,14516,131,14517,14518],"class_list":{"0":"post-23625","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-south-africa","8":"tag-animal-health-emergency","9":"tag-antigens","10":"tag-biogenesis-bago","11":"tag-fmd-disease-outbreak-in-south-africa","12":"tag-foot-and-mouth-disease","13":"tag-high-potency-vaccines","14":"tag-south-africa","15":"tag-vaccination","16":"tag-vaccines"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts\/23625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/comments?post=23625"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts\/23625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/media\/23626"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/media?parent=23625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/categories?post=23625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/tags?post=23625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}